ATE92081T1 - Tumorassoziiertes antigen. - Google Patents

Tumorassoziiertes antigen.

Info

Publication number
ATE92081T1
ATE92081T1 AT87303194T AT87303194T ATE92081T1 AT E92081 T1 ATE92081 T1 AT E92081T1 AT 87303194 T AT87303194 T AT 87303194T AT 87303194 T AT87303194 T AT 87303194T AT E92081 T1 ATE92081 T1 AT E92081T1
Authority
AT
Austria
Prior art keywords
antigen
associated antigen
tumor
molecular weight
ybm209
Prior art date
Application number
AT87303194T
Other languages
English (en)
Inventor
Karen Gray Burnett
Lana Suzanne Grauer
Esther Hui-Yim Oh
Original Assignee
Hybritech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hybritech Inc filed Critical Hybritech Inc
Application granted granted Critical
Publication of ATE92081T1 publication Critical patent/ATE92081T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1045—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
    • A61K51/1051—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants the tumor cell being from breast, e.g. the antibody being herceptin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3015—Breast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Biochemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT87303194T 1986-04-17 1987-04-13 Tumorassoziiertes antigen. ATE92081T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US85306786A 1986-04-17 1986-04-17
EP87303194A EP0243058B1 (de) 1986-04-17 1987-04-13 Tumorassoziiertes Antigen

Publications (1)

Publication Number Publication Date
ATE92081T1 true ATE92081T1 (de) 1993-08-15

Family

ID=25314945

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87303194T ATE92081T1 (de) 1986-04-17 1987-04-13 Tumorassoziiertes antigen.

Country Status (5)

Country Link
EP (1) EP0243058B1 (de)
JP (1) JPS62285798A (de)
AT (1) ATE92081T1 (de)
AU (2) AU7145087A (de)
DE (1) DE3786695T2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7144787A (en) * 1986-04-17 1987-10-22 Hybritech Inc. Tumor-associated antigen (mol wt 68,000-48000; 40,000-80000; 28000-32000; 16000-19000)
AU683413B2 (en) * 1992-04-13 1997-11-13 Dana-Farber Cancer Institute, Inc. Antibodies specific for carcinoma-associated antigens

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3329184A1 (de) * 1983-08-12 1985-02-21 Behringwerke Ag, 3550 Marburg Monoklonale antikoerper mit spezifitaet fuer membran-assoziierte antigene
EP0167616B1 (de) * 1984-01-06 1995-07-26 The Regents Of The University Of California Cytokeratin-tumormarkierer und test zu deren nachweis
AU7144787A (en) * 1986-04-17 1987-10-22 Hybritech Inc. Tumor-associated antigen (mol wt 68,000-48000; 40,000-80000; 28000-32000; 16000-19000)

Also Published As

Publication number Publication date
EP0243058B1 (de) 1993-07-28
EP0243058A3 (en) 1989-06-14
JPS62285798A (ja) 1987-12-11
DE3786695T2 (de) 1993-12-16
AU7145087A (en) 1988-10-13
AU5790390A (en) 1990-11-01
EP0243058A2 (de) 1987-10-28
AU640145B2 (en) 1993-08-19
DE3786695D1 (de) 1993-09-02

Similar Documents

Publication Publication Date Title
ATE117370T1 (de) Chimärer antikörper mit spezifität für menschliches tumor-antigen.
SE8202012L (sv) Humaninterferon-beslektade peptider, antigener, antikroppar och forfarande for framstellning derav
ES2116789T3 (es) Anticuerpos monoclonales (mak) contra antigenos asociados a tumores, su preparacion y empleo.
ATE132629T1 (de) Harnwegstumor-assoziiertes antigen, verwendung von antigenen untereinheiten und nachweisverfahren
GB2188941B (en) Monoclonal antibodies recognizing human interleukin-2-receptor
FI861692A0 (fi) En ny tumoerassocierad antigen.
ES8800603A1 (es) Un metodo para producir anticuerpos monoclonales
ATE92081T1 (de) Tumorassoziiertes antigen.
ATE86261T1 (de) Tumorassoziiertes antigen.
DK329789D0 (da) Monoklonalt antistof
DE3580524D1 (de) Monoklonaler antikoerper geeignet zur spezifischen unterscheidung von humanen hepatokarzinomzellen.
DE3579808D1 (de) Anti-urokinase monoklonaler antikoerper, seine herstellung und verwendung.
EP0397419A3 (de) Tumorassoziiertes Antigen, Antikörper sowie Zusammensetzungen und Verwendung hierfür
ATE125306T1 (de) Monoklonale antikörper, die einen unterschied zwischen nativproteinen und proteinen mit einer modifizierten sequenz machen.
EP0332421A3 (en) Monoclonal antibodies recognizing human psti, hybridomas producing the same, and their preparation and use

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties